Is your medication causing hyperkalemia? Know the relationship between drugs and high levels of potassium in this informative article.

Is your medication causing hyperkalemia? Know the relationship between medicines and high levels of potassium in this informative article.

Hyperkalemia is a condition in which blood potassium levels are abnormally high. Several factors can contribute to the development of hyperpotaia, including the use of certain medications. Drugs aimed at specific diseases can inadvertently affect potassium regulation in the body, causing an increase in potassium levels. Understanding the possible relationship between drugs and hyperkalemia is essential to guarantee patient safety and optimal medical treatment.

1. Specific drugs that cause hyperkalemia

  1. Angiotensin converting enzyme inhibitors (IECA): ECA inhibitors are usually prescribed for hypertension and heart failure. These medications act relaxing the blood vessels, but can also interfere with the excretion of potassium by the kidneys, which can cause an increase in potassium levels.
  2. Angiotensin Receptor Blockers (ARA): ARA are another kind of antihypertensive medications that can increase the risk of hyperkalemia. Like ECA inhibitors, ARAs can affect potassium excretion by kidneys, which causes potassium accumulation in the bloodstream.
  3. Potassium saving diuretics: although diuretics are often used to reduce fluid retention, some potassium saving diuretics can cause hyperpotsemia. These medications act by blocking the action of the aldosterone, a hormone that favors potassium excretion. Without the effects of aldosterone, potassium can accumulate in the body.

Important note: It is essential that health professionals be aware of the potential risks associated with these medications. Periodic monitoring of potassium levels during pharmacological treatment can help detect and treat hyperkalemia. The patient’s proper education about the signs and symptoms of potassium elevation is also essential to guarantee rapid medical intervention. Clinical decision making must imply the consideration of alternative medications or the adjustment of the doses when necessary, in order to minimize the risk of hyperkalemia.

2. Other contributing factors:

  • Renal insufficiency: patients with deterioration of renal function may be more likely to develop hyperkalemia due to the reduction of potassium excretion.
  • Drug interactions: The combination of certain medications can increase the risk of hyperpotsemia. For example, non-steroidal anti-inflammatories (NSAIDs), when used simultaneously with ECA or Ara-II inhibitors, can alter renal function and reduce potassium excretion.

Recognizing the potential role of drugs in hyperkalemia allows health professionals to apply adequate monitoring strategies and individualized treatment plans, guaranteeing the patient’s wel l-being and optimal therapeutic results.

Understanding Hyperkalemia: The Role of Drugs

Drugs can directly or indirectly affect potassium levels in the body, causing the development of hyperkalemia. Some medications can directly inhibit the excretion of potassium by the kidneys, leading to potassium retention and the consequent elevation of blood levels. On the other hand, certain medications can interfere with the normal functioning of cell potassium channels, altering the balance of potassium and sodium ions and causing hyperkalemia. It is important to point out that hyperpotsemia can occur as an adverse effect of these drugs, even when they are prescribed for other medical conditions.

Table 1: Drugs associated with hyperpota

Drug class Examples
RENINE-GETENSIN-ALDOSTERONE SYSTEM INHIBERS (MRSA) – Angiotensin (IECA) enzyme inhibitors – Angiotensin II (Ara) receptor blockers (ARA) – Aldosterone antagonists
Potassium saving diuretics – Spironolactona – Amilorida
No n-steroidal ant i-inflammatories (NSAIDs) – Ibuprofen – Naproxen – Celecoxib
Immunosuppressants – Tacrolimus – Cyclosporine

People who take medications from certain classes have a higher risk of developing hyperpotsemia. RENINE-GETENSIN-ALDOSTERONE (MRSA) system inhibitors such as angiotensin converting enzyme inhibitors (IECA), angiotensin II (ara) receptor antagonists and aldosterone antagonists, are usually prescribed to treatdiseases such as hypertension and heart failure. These drugs block the effects of substances that can increase blood pressure or fluid retention. However, they can also interfere with potassium balance in the organism, causing hyperpotsemia.

Another class of drugs that may contribute to hyperkalemia are potassium-sparing diuretics. Spironolactone and amiloride, for example, are diuretics that help the body eliminate excess fluid, but they can also reduce potassium excretion, which can cause hyperkalemia. Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs) and immunosuppressants have been associated with an increased risk of hyperkalemia.

What is Hyperkalemia?

Symptoms of hyperkalemia:

  • Muscle weakness or paralysis
  • Fatigue
  • irregular heartbeat
  • Nausea
  • Tingling or numbness
  • Difficulty breathing

It is important to keep in mind that hyperkalemia can be life-threatening, especially if not diagnosed and treated in time. Severe cases of hyperkalemia can lead to cardiac arrest requiring immediate medical intervention.

Causes of hyperkalemia

  1. Kidney dysfunction: The kidneys play a crucial role in maintaining potassium balance in the body. Any disturbance in kidney function can cause a decrease in potassium excretion, leading to its accumulation in the blood.
  2. Side effects of medications: Certain medications, such as angiotensin-converting enzyme inhibitors (ACE inhibitors) and nonsteroidal anti-inflammatory drugs (NSAIDs), can interfere with the regulation of potassium in the body, potentially causing hyperkalemia.
  3. Excessive potassium intake: Consuming high amounts of potassium through diet or supplements can overwhelm the body’s ability to eliminate excess potassium, leading to high blood levels.
potassium level Classification
5. 1-5. 5 mmol/L Mild hyperkalemia
5. 6-6. 0 mmol/L Moderate hyperkalemia
Above 6. 0 mmol/L Severe hyperkalemia

Common Drugs that Cause Hyperkalemia

1. Angiotensin-converting enzyme inhibitors (ACE inhibitors): ACE inhibitors are commonly prescribed to treat hypertension and heart failure. They work by blocking the action of the angiotensin-converting enzyme, which causes the relaxation of blood vessels and a decrease in fluid retention. However, ACE inhibitors can interfere with potassium regulation in the kidneys, causing hyperkalemia. Some examples of ACE inhibitors are lisinopril, enalapril, and ramipril.

  • ACE inhibitors can reduce the production of aldosterone, a hormone that helps regulate potassium levels in the body.
  • Patients taking ACE inhibitors should periodically monitor their potassium levels for any abnormalities.

2. Potassium saving diuretics: diuretics are usually prescribed to favor diuresis and reduce fluid retention in diseases such as hypertension and congestive heart failure. While most diuretics increase potassium excretion, potassium saving diuretics act by blocking the action of aldosterone, a hormone that favors potassium excretion. This mechanism can increase blood potassium levels and cause hyperkalemia. Some examples of potassium saving diuretics are Spironolactone and Amilorida.

  • Patients who take potassium saving diuretics should regularly control their potassium levels to prevent complications associated with hyperpotasemia.
  • The combination of potassium saving diuretics with ECA inhibitors or antagonists of angiotensin (ara) receptors can further increase the risk of hyperkalemia.
Drug class Examples
ECA inhibitors Lisinopril, Enalapril, Ramipril
Potassium saving diuretics SPIRONOLACTONA, AMILORIDA

Mechanisms of Drug-Induced Hyperkalemia

An important mechanism is the inhibition of the renal excretion of potassium by plots. Certain medications, such as angiotensin (ACEI) and angiotensin receptor antagonists (ARA), can interfere with the RENINE-ANTIGETENSIN-ALDOSTERONE (MRSA), causing a decrease in aldosterone production. Aldosterone plays a key role in the distal tubule of the kidney by promoting potassium secretion. When its production is inhibited, the ability of the kidneys to eliminate excess potassium is compromised, which causes hyperkalemia.

  • ECA inhibitors
  • ARA-II

“Inhibition of the Renin-Chartensin-Aldosterone System (Mrs.) by ECA inhibitors and ARAs can cause hyperpotasmia due to the decrease in the production of aldosterone and the consequent alteration of renal potassium excretion.”

Another mechanism that contributes to dru g-induced hyperkalemia is the interference with the potassium channels of the cell membrane. Certain medications, such as potassium saving diuretics and no n-selective beta blockers, can directly affect the function of these channels, causing a decrease in potassium movement outside the cells. Consequently, potassium accumulates in intracellular space, which raises serum levels.

  1. Potassium saving diuretics
  2. No n-selective beta blockers
Medication Mechanism of action
Potassium saving diuretics Inhibit sodium reabsorption in distal renal tubules and alter potassium secretion
No n-selective beta blockers They interfere with potassium efflux through the cell membrane channels

The understanding of the different mechanisms by which drugs can induce hyperkalemia allows health professionals to identify patients who may present a higher risk and adopt adequate preventive measures. To prevent the appearance of serious complications associated with hyperkalemia, it is essential to closely monitor serum potassium levels and adjust medication regimes accordingly.

Symptoms and Complications of Hyperkalemia


  • Weakness: A common symptom of hyperkalemia is muscle weakness. Patients may experience general weakness or weakness in specific muscle groups.
  • Irregular beats: high levels of potassium can alter normal electrical activity of the heart, causing irregular heart rhythms or even cardiac arrest.
  • Nausea and vomiting: Hyperpotsemia can cause gastrointestinal symptoms such as nausea, vomiting and abdominal pain.
  • Fatigue: excess blood potassium can contribute to the feeling of fatigue and tiredness.

It is important to point out that not all people with hyperpotasia have symptoms. In some cases, the condition can be asymptomatic, especially in its early stages. Regular control of potassium levels by blood analysis is essential for early detection and intervention.


Uncreated or poorly controlled hyperkalemia can cause various complications:

  1. Cardiac arrhythmias: high levels of potassium can alter normal electrical signals of the heart, causing potentially mortal arrhythmias.
  2. Renal dysfunction: Hyperpotasmia can alter renal function, reducing the body’s ability to regulate potassium levels in the body.
  3. Muscle paralysis: In severe cases, hyperkalemia can cause muscle paralysis, especially affecting the muscles involved in breathing.
  4. Cardiac arrest: If not, severe hyperkalemia can cause cardiac arrest, a potentially deadly condition in which the heart stops beating.

The proper treatment of hyperkalemia implies identifying the underlying cause, reducing potassium intake and implementing interventions to reduce blood potassium levels. Immediate medical care should be sought when hyperpotasemia symptoms occur or if it is known that there is a risk of high potassium levels.

Symptoms Complications
Muscular weakness Cardiac arrhythmias
irregular heartbeat Renal dysfunction
Nausea and vomiting Muscle paralysis
Fatigue Cardiac arrest

Diagnosis and Treatment of Drug-Induced Hyperkalemia


  1. Medical history: The collection of a detailed medical history of the patient, including any current or recent use of medications, is crucial to identify a possible dru g-induced hyperpotsemia.
  2. Laboratory tests: Blood analysis to measure potassium levels is vital to confirm hyperkalemia and determine its severity. In addition, renal function tests, such as serum creatinine levels and the estimated glomerular filtration rate, help evaluate renal function, which can contribute to hyperkalemia.
  3. Electrocardiogram (ECG): an ECG is performed to evaluate cardiac function and detect any possible anomaly associated with hyperpotsemia, such as peaks in T waves, prolonged PR intervals and widened QRS QRS.

Note: Early diagnosis is crucial, since dru g-induced hyperkalemia may require immediate medication interruption to avoid subsequent complications.


  • Dose adjustment or interruption of causative medications: identifying and suspending medication or medications responsible for dru g-induced hyperkalemia is a crucial step in treatment. This may imply the search for alternative treatment options or dose adjustment.
  • Calcium gluconate administration: Calcium gluconate, administered intravenously, can be used as a temporal measure to stabilize the excitability of the cardiac membrane while adding the underlying cause of hyperpotsemia.
  • Potassium reducing therapies: There are several medications to reduce blood potassium levels, such as ASA diuretics, sodium sulphonate polystyrene and bicarbonate therapy, which help improve potassium excretion or displace it intracellularly.
  • Regular control and monitoring: After initiating the treatment, a close control of potassium levels and renal function is essential to guarantee adequate control of hyperkalemia and evaluate the effectiveness of the chosen therapeutic approach. Periodic monitoring and adjustments of the treatment plan may be necessary.

Prevention and Management Strategies of Drug-Induced Hyperkalemia

Prevention strategies

  1. Exhaustive evaluation of medication: carrying out an exhaustive review of the patient’s medication regime is crucial to identify possible pharmacological interactions or adverse effects that may cause hyperpotarsmia. Health professionals must be attentive to prescribed medications, free sale and herbal supplements that can increase potassium levels.
  2. Education and advice: Patients should receive training on the risks associated with certain medications and be informed about the possible signs and symptoms of hyperkalemia. Health professionals should advise patients about the importance of respecting prescribed doses and any dietary restriction, especially in relation to foods rich in potassium.
  3. Regular electrolyte control: periodic monitoring of electrolyte levels, including potassium, in patients with dru g-induced hyperpotsemia is essential. This allows health professionals to identify any significant fluctuation in potassium levels and take appropriate measures to prevent complications.

Note: Preventive measures play a crucial role in mitigating the risk of dru g-induced hyperkalemia. The exhaustive evaluation of the medication regime of a patient, the effective education of the patient and the routine electrolyte monitoring can contribute significantly to the early detection and the prevention of hyperkalemia.

Management strategies

  • Interruption or adjustment of medication: If hyperpothasemia induced by medications is identified, health professionals should quickly interrupt or adjust the dose of medications that contribute to raising potassium levels. This may involve the replacement of medications with similar therapeutic effects but with less potential potassium increase.
  • Diuretic therapy: To treat hyperkalemia, diuretics can be prescribed, which favor the excretion of potassium through urine. The diuretics of the ASA, such as furosemide, are commonly used due to their powerful potassium reducing effects.
  • Potassium binders: potassium captors, such as sodium polystyrene sulfonate, can be administered to facilitate the elimination of excess potassium from the organism. These binders act by exchanging sodium ions by potassium ions in the intestines, reducing the total potassium load.

Note: The appropriate treatment strategies for dru g-induced hyperkalemia involve the interruption or adjustment of medication, diuretic treatment and the use of potassium binders to effectively normalize blood potassium levels.

Prevention strategies Management strategies
Exhaustive medication evaluation Interruption or adjustment of medication
Education and advice Diuretic therapy
Periodic electrolyte control Potassium fixers

Author of the article
Dr.Greenblatt M.
Dr.Greenblatt M.
Medical oncologist at the Robert Larner College of Medicine, MD, at the University of Vermont

Cannabis and Hemp Testing Laboratory
Add a comment